4-1BB Targeting Immunotherapy: Mechanism, Antibodies, and Chimeric Antigen Receptor T.

Shen, Xiaoling; Zhang, Rusong; Nie, Xiaojuan; Yang, Yanhua; Hua, Ye; Lü, Peng

Shen, Xiaoling; Zhang, Rusong; Nie, Xiaojuan; Yang, Yanhua; Hua, Ye; Lü, Peng.

Afiliação

Shen X; School of Life Sciences, Jiangsu University, Zhenjiang, China.
Zhang R; School of Life Sciences, Jiangsu University, Zhenjiang, China.
Nie X; School of Life Sciences, Jiangsu University, Zhenjiang, China.
Yang Y; School of Life Sciences, Jiangsu University, Zhenjiang, China.
Hua Y; Institute of Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Lü P; School of Life Sciences, Jiangsu University, Zhenjiang, China.

Cancer Biother Radiopharm ; 38(7): 431-444, 2023 Sep.

Article em En | MEDLINE | ID: mdl-37433196

Assuntos

Neoplasias; Receptores de Antígenos Quiméricos; Humanos; Ligantes; Neoplasias/terapia; Imunoterapia; NF-kappa B

Palavras-chave

4-1BB; CAR-T cells; antibodies; tumor therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google